Literature DB >> 12197344

Childhood visceral leishmaniasis complicated by bacterial infections.

M R Kadivar1, T Z Kajbaf, A Karimi, A Alborzi.   

Abstract

Bacterial superinfection is one of the major complications leading to death in patients with visceral leishmaniasis. We studied the frequency and type of bacterial infection in 54 patients admitted to hospital with visceral leishmaniasis. The patients were children who ranged in age from 3 1/2 months to 7 years. Bacterial infections were found in 22 (41%) of the patients. Bacteria were isolated in patients with pneumonia, septicaemia, otitis media, urinary tract infections and skin infections. Enterobacteriaceae were the most common bacterial agents isolated. In infants with visceral leishmaniasis, fatal bacterial infections can be accompanied by nonspecific signs and symptoms. Thus, it is important to initiate antibiotic treatment early.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12197344

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  10 in total

1.  Effectiveness of Short-Course Meglumine Antimoniate (Glucantime®) for Treatment of Visceral Leishmaniasis: A 13-Year, Multistage, Non-Inferiority Study in Iran.

Authors:  Abdolvahab Alborzi; Gholamreza Pouladfar; Armin Attar; Fatemeh Falahi; Zahra Jafarpour; Abdollah Karimi; Mohammad Rahim Kadivar
Journal:  Am J Trop Med Hyg       Date:  2016-11-22       Impact factor: 2.345

2.  Evaluation of serum procalcitonin levels for diagnosis of secondary bacterial infections in visceral leishmaniasis patients.

Authors:  Neda Pasyar; Abdolvahab Alborzi; Gholam R Pouladfar
Journal:  Am J Trop Med Hyg       Date:  2012-01       Impact factor: 2.345

Review 3.  Parasite-bacteria interrelationship.

Authors:  Dalia S Ashour; Ahmad A Othman
Journal:  Parasitol Res       Date:  2020-08-04       Impact factor: 2.289

4.  Effects of tropism and virulence of Leishmania parasites on cytokine production by infected human monocytes.

Authors:  A Meddeb-Garnaoui; H Zrelli; K Dellagi
Journal:  Clin Exp Immunol       Date:  2008-11-20       Impact factor: 4.330

5.  Pediatric visceral leishmaniasis in northwest of Iran.

Authors:  Babak Abdinia; Mohammad Oliaei-Motlagh; Amir Teimouri-Dereshki
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

6.  Epidemiological features of visceral leishmaniasis in fars province, southern iran.

Authors:  B Sarkari; G Hatam; Ma Ghatee
Journal:  Iran J Public Health       Date:  2012-04-30       Impact factor: 1.429

7.  Bacterial sepsis in patients with visceral leishmaniasis in Northwest Ethiopia.

Authors:  Mengistu Endris; Yegnasew Takele; Desalegn Woldeyohannes; Moges Tiruneh; Rezika Mohammed; Feleke Moges; Lutgarde Lynen; Jan Jacobs; Johan van Griensven; Ermias Diro
Journal:  Biomed Res Int       Date:  2014-05-06       Impact factor: 3.411

8.  Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation.

Authors:  Wafa Markikou-Ouni; Sima Drini; Narges Bahi-Jaber; Mehdi Chenik; Amel Meddeb-Garnaoui
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

9.  Visceral Leishmaniasis in Southwestern Iran: A Retrospective Clinico-Hematological Analysis of 380 Consecutive Hospitalized Cases (1999-2014).

Authors:  Bahador Sarkari; Tahereh Naraki; Mohammad Amin Ghatee; Samaneh Abdolahi Khabisi; Mohammad Hassan Davami
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

10.  Fatal progression of experimental visceral leishmaniasis is associated with intestinal parasitism and secondary infection by commensal bacteria, and is delayed by antibiotic prophylaxis.

Authors:  Michael D Lewis; Andrea Paun; Audrey Romano; Harry Langston; Charlotte A Langner; Ian N Moore; Kevin W Bock; Amanda Fortes Francisco; Jason M Brenchley; David L Sacks
Journal:  PLoS Pathog       Date:  2020-04-13       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.